Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Female allogeneic hematopoietic cell transplant survivors' perspectives on cervical cancer screening: a retrospective study.
Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFemale allogeneic hematopoietic cell transplantation (AlloHCT) survivors are at increased risk for human papillomavirus (HPV)-related malignancies due to immunosuppression. Guidelines recommend annual cervical cancer screening for AlloHCT survivors with a cervix aged 21-65. This study explored cervical cancer screening knowledge, behaviors, attitudes, experiences, and preferences-specifically provider-collected versus self-collected methods-and identified adherence barriers and facilitators.
methodsWe conducted a mixed-methods observational study of female AlloHCT survivors aged 21-65 who received AlloHCT at Oregon Health & Science University between 2012 and 2023. Participants completed demographic surveys and participated in focus groups exploring screening adherence, perceptions, and preferences.
resultsTwenty-three survivors completed the survey, and 16 joined focus groups in fall 2024. The median participant age was 49 years (range 32-61); most were white (87%) and privately insured (91%). Median age at bone marrow transplantation (BMT) was 41 years (range 19-56). Primary diagnosis included acute myeloid leukemia or myelodysplastic syndrome (65%). Reported complications included graft versus host disease (GVHD) (44%), chronic GVHD (39%), and vaginal GVHD (22%). Awareness of increased cervical cancer risk facilitated screening adherence, while limited access to in-network providers was a barrier. All participants preferred provider-collected screening due to confidence in test accuracy and reassurance from clinician involvement. Psychological factors, particularly worrying about recurrence or secondary cancers, strongly influenced screening preferences.
conclusionCervical cancer screening preferences among AlloHCT survivors were shaped by physical and psychological treatment-related factors. HPV self-collection may be a supplemental option before BMT, between annual clinic visits, or when access barriers arise.
Indexed as
Identifiers
42527718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.